LHCSX Mutual Fund

LHCSX Mutual Fund

NAV$23.52
See how much of LHCSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 62 holdings · as of Jun 30, 2026
LHCSX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
10.93%		10.9%775$929.6KHealth CarePharmaceuticals
2
UNH
Unitedhealth Group IncHealth Care · Healthcare Services
4.48%		15.4%917$381.1KHealth CareHealthcare Services
Sector and industry · Pro
3—AstraZeneca PLC
4.46%		19.9%2,029$379.5K
4
GH
Guardant Health, Inc
4.34%		24.2%2,459$368.9K
5
NTRA
Natera Inc
3.67%		27.9%1,151$312.4K
6
GILD
Gilead Sciences
3.45%		31.3%2,323$293.5K
7
JNJ
Johnson & Johnson -
3.37%		34.7%1,129$286.7K
8—Cvs Corp
3.33%		38.0%2,734$282.8K
9
NVS
Novartis Ag Ordinary Shares
3.01%		41.0%1,633$255.8K
10
GALD
Galderma
2.74%		43.8%1,023$232.8K
11
COGT
Cogent Biosciences Inc
2.27%		46.1%4,983$192.8K
12
MDGL
Madrigal Pharmaceuticals Inc
2.21%		48.3%350$187.9K
13
ASND
Ascendis Pharma A/S
2.19%		50.5%698$186.2K
14—Argenx Se
2.17%		52.6%199$184.5K
15
MIRM
Mirum Pharmaceuticals, Inc.
2.02%		54.6%1,467$171.7K
16
EW
Edwards Lifesciences Corp
1.89%		56.5%1,775$160.6K
17
ISRG
Intuitive Surgical Inc.
1.84%		58.4%393$156.3K
18—Nvaesrtex Pharmaceuticals Inc
1.82%		60.2%311$154.5K
19
TXG
10x Genomics Inc Com Usd 1 Cl A
1.76%		62.0%3,910$149.9K
20
RVMD
Revolution Medicines Inc
1.68%		63.6%764$143.1K
21—Ucb Sa
1.58%		65.2%450$134.7K
22
PTCT
Ptc Therapeutics Inc
1.57%		66.8%1,632$133.1K
23
TMO
Thermo Fisherscientific Inc.
1.49%		68.3%252$126.3K
24
UTHR
United Therapeutics Corp
1.49%		69.8%234$126.8K
25
ARWR
Arrowhead Pharmaceuticals Inc
1.47%		71.2%1,538$125.4K
26
ADPT
Adaptive Biotechnologies Corp
1.36%		72.6%5,407$116.0K
27—Beone Medicines Ltd
1.35%		73.9%5,286$114.8K
28
DNTH
Dianthus Therapeutics Inc
1.32%		75.3%1,152$112.3K
29
BBIO
Bridgebio Pharma Inc_None_0
1.30%		76.6%1,480$110.2K
30
PTGX
Protagonist Therapeutics Inc
1.30%		77.9%905$110.9K
31
ILMN
Illumina, Inc.
1.23%		79.1%594$104.4K
32—Teva Pharmaceutical Industries Limited (Adr)
1.18%		80.3%2,957$100.2K
33—Otsuka Holdings
1.13%		81.4%1,448$96.2K
34—Roivant Sciences Ltd. Common Shares
1.11%		82.5%2,674$94.6K
35
CELC
Celcuity Inc
1.10%		83.6%896$93.7K
36
GKOS
Glaukos Corp.
1.10%		84.7%671$93.8K
37
HNGE
Hinge Health Inc
1.10%		85.8%1,123$93.2K
38
CGON
Cg Oncology Inc
1.02%		86.8%1,223$86.9K
39—Newamsterdam Pharma Nv
0.99%		87.8%2,496$84.6K
40
ORKA
Oruka Therapeutics Inc Orka
0.93%		88.7%828$78.8K
41
ELVN
Enliven Therapeutics Inc
0.88%		89.6%1,478$75.0K
42
WST
West Pharmaceutical Services Inc
0.86%		90.5%204$73.2K
43
HTFL
Heartflow, Inc.
0.81%		91.3%2,360$69.2K
44—Emcompass Health Corp
0.80%		92.1%677$68.4K
45
PRAX
Praxis Precision Medicines, Inc.
0.76%		92.9%193$64.6K
46
TNGX
Tango Therapeutics Inc.
0.74%		93.6%2,000$62.5K
47
TARS
Tarsus Pharmaceuticals Inc
0.73%		94.3%983$61.9K
48
ALMS
Alumis Inc
0.72%		95.0%2,183$61.4K
49—Stryker Corp 3.375 11/25
0.69%		95.7%186$58.6K
50—DBV Technologies S.A. American Depositary Shares, Each Representing One-Half Of Five Ordinary Share, Nominal Value 0.10 Per Share
0.57%		96.3%2,973$48.8K
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 12 holdings of LHCSX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

LHCSX Mutual Fund All Holdings

LHCSX holdings total 64 positions. The top 10 holdings account for 43.8% of the fund, led by Eli Lilly & Co. at 10.9%, Unitedhealth Group Incorporated at 4.5%, AstraZeneca PLC at 4.5%.

LHCSX portfolio concentration is moderate, with the top 10 representing 43.8% of total assets. The largest sector exposure is Health Care at 82.0%.

LHCSX sectors provide a detailed breakdown. LHCSX overlap shows how holdings compare to other funds in your portfolio.